Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
P03277 Dose Finding in CNS MRI
NCT02633501Phase 2Completed
- Sponsor
- Guerbet
- Start
- Jun 2016
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of gadopiclenol in Central nervous system lesion, sponsored by Guerbet. Started Jun 2016; status: completed.
02
Drugs
gadopiclenol
03
Conditions
Central nervous system lesion
Beyond the preview
Go deeper on NCT02633501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02633501.